The Doctrine of Original Antigenic Sin: Separating Good from Evil

Journal of Infectious Diseases

Volumn 215, Issue 12, 2017, Pages 1782-1788

  Monto, Arnold S ^a   Malosh, Ryan E ^a   Petrie, Joshua G ^a   Martin, Emily T ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

immune response.; Influenza

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIGEN;

2009 H1N1 INFLUENZA; COHORT ANALYSIS; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H2N2); INFLUENZA A (H3N2); INFLUENZA A VIRUS (A/ENGLAND/42/72(H3N2)); INFLUENZA A VIRUS (A/HONGKONG/X31/68(H3N2)); INFLUENZA A VIRUS (A/VICTORIA/3/75(H3N2)); INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H2N2); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VIRUS STRAIN; ANTIBODY PRODUCTION; HISTORY; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS; PHYSIOLOGY; TRENDS; VACCINATION;

ANTIBODY FORMATION; ANTIGENS, VIRAL; HISTORY, 20TH CENTURY; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 85022333781     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix173     Document Type: Review

References (50)

1. Francis T. On the doctrine of original antigenic sin. Proc Am Philos Soc 1960; 104:572-578
2. Viboud C, Epstein SL. First flu is forever. Science 2016; 354:706-7
3. Gostic KM, Ambrose M, Worobey M, Lloyd-Smith JO. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science 2016; 354:722-6
4. Salk JE, Menke WJ, Francis T. A clinical, epidemiological and immunological evaluation op vaccination against epidemic influenza. Am J Epidemiol 1945; 42:57-93
5. Francis T Jr, Salk JE, Quilligan JJ Jr. Experience with vaccination against influenza in the spring of 1947; a preliminary report. Am J Public Health Nations Health 1947; 37:1013-6
6. Nelson MI, Viboud C, Simonsen L, et al. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLOS Pathog 2008; 4:e1000012
7. Davenport FM, Hennessy AV. A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine. J Exp Med 1956; 104:85-97
8. Davenport FM, Hennessy AV. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines. J Exp Med 1957; 106:835-50
9. Jensen KE, Davenport FM, Hennessy AV, Francis T Jr. Characterization of influenza antibodies by serum absorption. J Exp Med 1956; 104:199-209
10. Fazekas De St G, Webster RG. Disquisitions of original antigenic sin. I. Evidence in man. J Exp Med 1966; 124:331-45
11. Webster RG. Original antigenic sin in ferrets: the response to sequential infections with influenza viruses. J Immunol 1966; 97:177-83
12. Davenport FM. Protective efficacy of inactivated influenza vaccines, 1943-1969. Med J Aust 1973; :33-8
13. Mulder J, Masurel N. Pre-epidemic antibody against 1957 strain of Asiatic influenza in serum of older people living in the Netherlands. Lancet 1958; 1:810-4
14. Hoskins TW, Davies JR, Allchin A, Miller CL, Pollock TM. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. Lancet 1973; 2:116-20
15. Hoskins TW, Davies JR, Smith AJ, Allchin A, Miller CL, Pollock TM. Influenza at Christ's Hospital: March, 1974. Lancet Lond Engl 1976; 1:105-108
16. Hoskins TW, Davies JR, Smith AJ, Miller CL, Allchin A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet 1979; 1:33-5
17. Beyer WE, De Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. The plea against annual influenza vaccination 'The Hoskins' Paradox' revisited. Vaccine 1998; 16:1929-32
18. Smith DJ, Lapedes AS, De Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004; 305:371-6
19. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011; 203:1309-15
20. Beyer WE, Palache AM, Sprenger MJ, et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996; 14:1331-9
21. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988; 127:353-64
22. Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997; 15:1114-22
23. Beyer WE, De Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: A meta-analysis of serologic and field studies. Arch Intern Med 1999; 159:182-8
24. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A 1999; 96:14001-6
25. Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56:1363-9
26. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27
27. Mclean HQ, Thompson MG, Sundaram ME, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 2014; 59:1375-85
28. Valenciano M, Kissling E, Reuss A, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of cocirculation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Euro Surveill 2016; 21:pii=30139
29. Skowronski DM, Chambers C, Sabaiduc S, et al. A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-2015 season. Clin Infect Dis 2016; 63:21-32
30. Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010; 7:e1000258
31. Monto AS, Koopman JS, Longini IM Jr. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol 1985; 121:811-22
32. Powers DC, Belshe RB. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and "original antigenic sin". J Infect Dis 1994; 169:1125-9
33. Adalja AA, Henderson DA. Original antigenic sin and pandemic (H1N1) 2009. Emerg Infect Dis 2010; 16:1028-9
34. Morens DM, Burke DS, Halstead SB. The wages of original antigenic sin. Emerg Infect Dis 2010; 16:1023-4
35. Hardelid P, Andrews NJ, Hoschler K, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess 2010; 14:115-92
36. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-52
37. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405-13
38. Choi YS, Baek YH, Kang W, et al. Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination. Clin Vaccine Immunol 2011; 18:1519-23
39. Ohfuji S, Fukushima W, Deguchi M, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 2011; 203:1301-8
40. Uno S, Kimachi K, Kei J, et al. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: A randomized controlled trial. Microbiol Immunol 2011; 55:783-9
41. Jackson LA, Chen WH, Stapleton JT, et al. Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis 2012; 206:811-20
42. Gulati U, Kumari K, Wu W, Keitel WA, Air GM. Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination. Vaccine 2005; 23:1414-25
43. Kim JH, Skountzou I, Compans R, Jacob J. Original antigenic sin responses to influenza viruses. J Immunol 2009; 183:3294-301
44. O'donnell CD, Wright A, Vogel L, Boonnak K, Treanor JJ, Subbarao K. Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus. Clin Vaccine Immunol 2014; 21:737-46
45. Laurie KL, Carolan LA, Middleton D, Lowther S, Kelso A, Barr IG. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis 2010; 202:1011-20
46. Bodewes R, Kreijtz JH, Geelhoed-Mieras MM, et al. Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J Virol 2011; 85:2695-702
47. Bodewes R, Fraaij PL, Geelhoed-Mieras MM, et al. Annual vaccination against influenza virus hampers development of virus-specific CD8 T cell immunity in children. J Virol 2011; 85:11995-2000
48. Petrie JG, Monto AS. Untangling the effects of prior vaccination on subsequent influenza vaccine effectiveness. J Infect Dis 2017; 215:841-3
49. Treanor JJ. Flu vaccine-too much of a good thing J Infect Dis 2017; 215:1017-9
50. Petrie JG, Parkhouse K, Ohmit SE, Malosh RE, Monto AS, Hensley SE. Antibodies against the current influenza A(H1N1) vaccine strain do not protect some individuals from infection with contemporary circulating influenza A(H1N1) virus strains. J Infect Dis 2016; 214:1947-51.